
2010/10/01
Blood test developed for non-alcoholic fatty liver disease diagnosis
Researchers from the Metabolomics unit at CICbioGUNE-CIBERehd and OWL Genomics Ltd. (Bilbao, Spain) have used metabolomics technology to develop a blood test for non-alcoholic fatty liver disease (NAFLD) diagnosis. This research has been recently published in The Journal of Proteome Research. OWL Genomics Ltd. is beginning to commercialize this new test in Spain.
See a large version of the first picture